GlassScriptPhysician profile
Andrew Campbell
NPI 1225727423
$2,064.67
in general payments reported to CMS, 2019-2025
27 companies · $864 in 2025
The $864 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $448 · 2024: $753 · 2025: $864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,064.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $322.56 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $177.55 | 2023-2024 | Prolaris |
| Janssen Biotech, INC. | $176.43 | 2023-2025 | Erleada |
| Boston Scientific Corporation | $167.18 | 2023-2025 | Xpeeda Dsl Fiber, Ams 700, Advance Xp |
| Pfizer INC. | $131.19 | 2023-2024 | |
| Laborie Medical Technologies Corp. | $114.55 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $96.81 | 2024-2025 | |
| Astellas Pharma US INC | $94.98 | 2025 | Xtandi, Padcev |
| Merck Sharp & Dohme LLC | $84.10 | 2024-2025 | Keytruda |
| Endo USA, INC. | $81.21 | 2025 | Xiaflex, Aveed |
| Abbvie INC. | $71.31 | 2024-2025 | |
| Blue Earth Diagnostics | $58.54 | 2023 | |
| Urogen Pharma, INC. | $55.62 | 2025 | |
| Convatec INC. | $55.14 | 2024 | |
| Ferring Pharmaceuticals INC. | $53.96 | 2025 | Adstiladrin |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $42.65 | 2024-2025 | Urolift |
| Innovation Technologies INC | $38.22 | 2024 | Irrisept |
| Progenics Pharmaceuticals, INC. | $38.21 | 2023-2024 | Pylarify |
| Antares Pharma, INC. | $34.80 | 2024-2025 | Xyosted |
| Procept Biorobotics Corporation | $33.01 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.74 | 2024 | |
| Novo Nordisk INC | $22.12 | 2024 | |
| Halozyme INC | $20.49 | 2023 | |
| Endo Pharmaceuticals INC. | $19.62 | 2023 | Xiaflex |
| Abc Home Medical Supply, INC. | $15.45 | 2025 | |
| Hollister Incorporated | $15.17 | 2023 | Infyna Chic, Vapro, Vapro Pocket |
| 180 Medical, INC. | $14.06 | 2024 | Gentlecath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.